Di Lorenzo D, Villa R, Biasiotto G, Belloli S, Ruggeri G, Albertini A, Apostoli P, Raviscioni M, Ciana P, Maggi A
3rd Laboratory/Biotechnology, Civic Hospital of Brescia, University of Brescia, 25123 Brescia, Italy.
Endocrinology. 2002 Dec;143(12):4544-51. doi: 10.1210/en.2002-220448.
We investigated the tissue-specific effects of dichlorodyphenyltrichloroethane (DDT) isomers in adult and suckling newborn mice, using a novel mouse line engineered to express a reporter of estrogen receptor transcriptional activity (ERE-tkLUC mouse). The DDT isomers p,p'-DDT [1,1,1-trichloro2,2-bis(p-chlorophenyl) ethane] and o,p'-DDT [1,1,1-trichloro-2(p-chlorophenyl)-2-(o-chlorophenyl) ethane] were specifically selected as a weak and a strong estrogen, respectively. In adult male mice, p,p'-DDT induced luciferase activity in liver, brain, thymus, and prostate but not in heart and lung. The effect of p,p'-DDT was dose-dependent, maximal at 16 h after sc treatment, and completely blocked by the estrogen receptor antagonist ICI-182,780. In all the organs analyzed, except the liver, administration of o,p'-DDT showed a pattern of luciferase induction superimposable to that of its isomer p,p'-DDT. In liver, o,p'-DDT significantly decreased basal luciferase activity and blocked the reporter induction by 17beta-estradiol. These data lead us to hypothesize that a modulation of ER activity may be involved in the toxic effects of DDT demonstrated by epidemiological and experimental studies. Luciferase activity was also studied in 4-d-old mice lactating from a mother injected with either p,p'-DDT or o,p'-DDT. Both isomers induced a 2-fold increase in the newborn brain. An opposite effect was observed in liver, where p,p'-DDT increased and o,p'-DDT decreased luciferase, thus indicating that these compounds modulate ER activity in adult and newborn tissues by use of a similar mechanism. The ERE-tkLUC mouse proves to be a suitable tool to functionally assess the tissue specificity of estrogenic/antiestrogenic compounds in adult (as well as in suckling) mice.
我们使用一种经过基因工程改造以表达雌激素受体转录活性报告基因的新型小鼠品系(ERE-tkLUC小鼠),研究了二氯二苯基三氯乙烷(DDT)异构体对成年和哺乳新生小鼠的组织特异性影响。DDT异构体p,p'-DDT [1,1,1-三氯-2,2-双(对氯苯基)乙烷] 和o,p'-DDT [1,1,1-三氯-2(对氯苯基)-2-(邻氯苯基)乙烷] 分别被特意选为弱雌激素和强雌激素。在成年雄性小鼠中,p,p'-DDT可诱导肝脏、大脑、胸腺和前列腺中的荧光素酶活性,但在心脏和肺中则不能。p,p'-DDT的作用呈剂量依赖性,皮下注射后16小时达到最大值,并被雌激素受体拮抗剂ICI-182,780完全阻断。在所有分析的器官中,除肝脏外,给予o,p'-DDT后荧光素酶诱导模式与其异构体p,p'-DDT的模式可叠加。在肝脏中,o,p'-DDT显著降低基础荧光素酶活性,并阻断17β-雌二醇诱导的报告基因。这些数据使我们推测,雌激素受体活性的调节可能参与了流行病学和实验研究中所证明的DDT的毒性作用。还研究了从注射了p,p'-DDT或o,p'-DDT的母亲处哺乳的4日龄小鼠的荧光素酶活性。两种异构体均使新生小鼠大脑中的荧光素酶活性增加了2倍。在肝脏中观察到相反的效果,其中p,p'-DDT使荧光素酶增加,而o,p'-DDT使荧光素酶减少,这表明这些化合物通过类似机制调节成年和新生组织中的雌激素受体活性。ERE-tkLUC小鼠被证明是在成年(以及哺乳)小鼠中功能评估雌激素/抗雌激素化合物组织特异性的合适工具。